Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Maffezzini

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Anticancer Research|May 1, 2007
Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancerFabio Campodonico, Francesca Mattioli, Valeria Manfredi, et al.
Surgical Oncology|December 24, 2004
Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderlyMassimo Maffezzini, Guido Gerbi, Fabio Campodonico, et al.
Anticancer Research|December 1, 2010
Prognostic significance of fluorescent in situ hybridisation in the follow-up of non-muscle-invasive bladder cancerMassimo Maffezzini, Fabio Campodonico, Giacomo Capponi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 26, 2006
Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsyFabio Campodonico, Antonio Casarico, Lorenzo Gavazzi, et al.
Urologia Internationalis|February 14, 2004
A simple mathematical approach to calculate blood loss in radical prostatectomyRodolfo Hurle, Rossana Poma, Massimo Maffezzini, et al.
Critical Reviews in Oncology/Hematology|February 14, 2002
Bladder cancerFilippo de Braud, Massimo Maffezzini, Vito Vitale, et al.
Urology|June 25, 2013
Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle-invasive bladder cancerMassimo Maffezzini, Fabio Campodonico, Egi E Manuputty, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 23, 2021
Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patientsMassimo Maffezzini, Vincenzo Fontana, Andrea Pacchetti, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 10, 2024
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotypeValentina Doldi, Monica Tortoreto, Maurizio Colecchia, et al.
Oncotarget|September 17, 2015
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activationValentina Doldi, Maurizio Callari, Elisa Giannoni, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Anticancer Research|May 1, 2007
Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancerFabio Campodonico, Francesca Mattioli, Valeria Manfredi, et al.
Surgical Oncology|December 24, 2004
Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderlyMassimo Maffezzini, Guido Gerbi, Fabio Campodonico, et al.
Anticancer Research|December 1, 2010
Prognostic significance of fluorescent in situ hybridisation in the follow-up of non-muscle-invasive bladder cancerMassimo Maffezzini, Fabio Campodonico, Giacomo Capponi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 26, 2006
Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsyFabio Campodonico, Antonio Casarico, Lorenzo Gavazzi, et al.
Urologia Internationalis|February 14, 2004
A simple mathematical approach to calculate blood loss in radical prostatectomyRodolfo Hurle, Rossana Poma, Massimo Maffezzini, et al.
Critical Reviews in Oncology/Hematology|February 14, 2002
Bladder cancerFilippo de Braud, Massimo Maffezzini, Vito Vitale, et al.
Urology|June 25, 2013
Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle-invasive bladder cancerMassimo Maffezzini, Fabio Campodonico, Egi E Manuputty, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 23, 2021
Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patientsMassimo Maffezzini, Vincenzo Fontana, Andrea Pacchetti, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 10, 2024
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotypeValentina Doldi, Monica Tortoreto, Maurizio Colecchia, et al.
Oncotarget|September 17, 2015
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activationValentina Doldi, Maurizio Callari, Elisa Giannoni, et al.
Pageof 8